Optimizing Care for Patients With CML Through Team-Based Education and Clinical Resources

Learn how experts manage CML with TKIs through focused expert-authored commentaries a CME/CE/CPE-certified interactive text module with expert&rsquo s insights on the latest clinical data and downloadable slides from this program. Download the pharmacist case manager and patient navigator PDF resource and the CML Interactive Decision Support Tool to tailor your treatment decisions to individual patients.

Share

Program Content

Activities

CML and Comorbidities
My Thoughts on Managing Patients With CML and Comorbidities
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 03, 2021

Expires: November 02, 2022

TKIs in CML
How I Individualize TKI Therapy for Patients With CML
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 13, 2021

Expires: December 12, 2022

BCR-ABL1: Adherence
How I Manage Adherence Issues in Patients Receiving BCR-ABL1 Inhibitor Therapy for CML
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 02, 2022

Expires: March 01, 2023

Activities

CML HCP Pocket Guide
Improving Patient Access to TKI-Based Therapy for CML: A Resource Guide
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: January 12, 2022

Expires: January 11, 2023

Activities

Team Quality Care in CML
Essentials to Deliver Quality Care for Patients With CML: A Team Approach
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: March 01, 2022

Expires: February 28, 2023

Slideset: Team Quality Care in CML
Essentials to Deliver Quality Care for Patients With CML: A Team Approach
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 01, 2022

Expires: February 28, 2023

Activities

Monitoring Response to BCR-ABL1 inhibitors in CML
Chronic Myeloid Leukemia Interactive Decision Support Tool: Expert Guidance on Monitoring Response to BCR-ABL1 Inhibitors in CML
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: March 30, 2022

Expires: March 29, 2023

Faculty

cover img faculity

Jorge Cortes, MD

Professor of Medicine
Deputy Chair, Department of Leukemia
M.D. Anderson Cancer Center
Houston, Texas

cover img faculity

Daniel J. DeAngelo, MD, PhD

Associate Professor of Medicine
Department of Medicine
Harvard Medical School
Clinical Director, Adult Leukemia Program
Department of Medical Oncology
Division of Hematologic Malignancies
Dana-Farber Cancer Institute
Boston, Massachusetts

 

cover img faculity

Smith B Douglas

cover img faculity

Michael J. Mauro, MD

Associate Professor
Knight Cancer Institute, Center for Hematologic Malignancies
Oregon Health and Science University
Portland, Oregon

cover img faculity

Jerald Radich, MD

Member
Clinical Research Division
Fred Hutchinson Cancer Research Center
Seattle, Washington

cover img faculity

Caitlin R. Rausch, PharmD, BCOP

Clinical Pharmacy Specialist, Leukemia
MD Anderson Cancer Center
Houston, Texas

cover img faculity

Neil P. Shah, MD, PhD

Assistant Professor
Division of Hematology/Oncology
University of California, San Francisco
San Francisco, California

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Novartis Pharmaceuticals Corporation

Pfizer, Inc.